DF

David Frendewey

RP Regeneron Pharmaceuticals: 8 patents #9 of 110Top 9%
Harvard University: 1 patents #101 of 493Top 25%
📍 New York, NY: #55 of 2,310 inventorsTop 3%
🗺 New York: #436 of 12,278 inventorsTop 4%
Overall (2017): #12,282 of 506,227Top 3%
8
Patents 2017

Issued Patents 2017

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
9834786 Nuclease-mediated targeting with large targeting vectors Wojtek Auerbach, David M. Valenzuela, George D. Yancopoulos, Ka-Man Venus Lai 2017-12-05
9745598 miRNA-regulated differentiation-dependent self-deleting cassette David Heslin, Ka-Man Venus Lai, David M. Valenzuela 2017-08-29
9730434 Methods and compositions for generating a mouse William Poueymirou, Thomas M. DeChiara, Wojtek Auerbach, David M. Valenzuela 2017-08-15
9677129 Method for detecting the replacement of an endogenous allele with a modified allele by homologous recombination in a mouse ES cell Aris N. Economides, Andrew J. Murphy, David M. Valenzuela, George D. Yancopoulos 2017-06-13
9677086 Promoter-regulated differentiation-dependent self-deleting cassette Guochun Gong, Ka-Man Venus Lai, David M. Valenzuela 2017-06-13
9655351 Production of fertile XY female animals from XY ES cells Wojtek Auerbach, Thomas M. DeChiara, William Poueymirou, David M. Valenzuela 2017-05-23
9554564 IncRNA-knockout mice Ka-Man Venus Lai, Guochun Gong, John Rinn, David M. Valenzuela 2017-01-31
9546384 Methods and compositions for the targeted modification of a mouse genome Wojtek Auerbach, Ka-Man Venus Lai, David M. Valenzuela, George D. Yancopoulos 2017-01-17